News
Amidst the continued struggle to treat non-small-cell lung cancer, a new study led by Stanford University scientists suggests that a patient's response to immunotherapy may hinge on how immune cells ...
Radiation therapy can treat lung cancer at all stages, easing symptoms, improving precision and minimizing side effects with ...
2don MSN
A groundbreaking technology designed to attack lung tumors and shorten recovery times for patients is now available at St.
Researchers from The University of Texas MD Anderson Cancer Center have identified a new biomarker, TTF-1, that was ...
qXR-LN is an FDA-cleared solution to assist physicians with early nodule detection. Studies have shown that AI is highly ...
1d
News-Medical.Net on MSNTTF1 identified as key biomarker for advanced KRAS G12C-mutated non-small cell lung cancerResearchers from The University of Texas MD Anderson Cancer Center have identified a new biomarker, TTF-1, that was ...
Tumor DNA in the Blood Can Predict Lung Cancer Outcome Jan. 13, 2025 — Scientists have found that a test to detect circulating tumor DNA can predict lung cancer ... Jan. 9, 2025 — Researchers ...
Background. A 48-year-old man presented with diarrhea, flushing, abdominal pain and weight loss of 10 kg over a 6-month period. He subsequently developed dyspnea on exertion. Diagnosis. Carcinoid ...
Impaired T cell and neoantigen retention in time-serial analysis of metastatic non-small cell lung cancer in patients unresponsive to TIL cell therapy. Nature Cancer , 2025; DOI: 10.1038/s43018 ...
The U.S. Food and Drug Administration has approved AbbVie's drug to treat adults with a type of lung cancer who have received previous treatment, the drugmaker said on Wednesday.
Some tumors contain cells that are both SCLC and a form of NSCLC (often large cell), according to the GO 2 for Lung Cancer foundation. (1) Doctors must know the type of cancer you have to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results